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Objectives: To estimate the correlation between the total heart calcification score index (CSI), assessed by echocardiography, left ventricle
mass index (LVMI), Framingham risk score (FRS), and angiographically assessed coronary artery disease (CAD).
Background: Aortic valve and root sclerosis (AVS, ARS) and mitral annular calcium (MAC) detected by echocardiography have been
associated with atherosclerosis. FRS is recommended for estimation of total coronary heart disease risk over the course of 10 years. The
anatomic extent of CAD can be assessed with coronary angiography. Total and cardiovascular mortality risk increases with increasing LVMI.
Methods: 167 consecutive in-hospital patients (mean age 66.6±9.7 yrs, 119 men) underwent: 1) complete transthoracic echocardiography
(TTE), with CSI assessment (from 0=normal to 10=diffuse calcification of aortic valve, mitral annulus and aortic root), 2) the FRS
evaluation (FRS≤10=low, FRS≥11 and ≤20=average risk, and a FRS≥21=high risk), and 3) coronary angiography (with Duke score
evaluation, from 0=normal to 100=severe left main disease).
Results: The mean CSI of the entire population was 3.94±2.1, with a mean of 2.75±2 in patients at low risk, with a progressive increase in
patients at average risk (4.11±2.2), at high risk (4.7±1.7), respectively. CSI was associated with the presence of CAD ( p=0.003) and the
presence of abnormal LVMI (p=0.002).
Conclusions: Echocardiographically assessed CSI is correlated to FRS, Duke score and LVMI and can provide a simple, radiation-free index
of cardiovascular risk.
© 2009 Elsevier Ireland Ltd. All rights reserved.Keywords: Calcification; Echocardiography; Framingham risk score; Coronary artery disease1. Background
Atherosclerotic disease is characterized by the accumula-
tion of lipid material in the arterial wall resulting from auto-
immune and inflammatory mechanisms [1]. More than 90%
of these fatty plaques undergo calcification [2]. Vascular cal-Abbreviations: AVS, aortic valve sclerosis; ARS, aortic root sclerosis;
CAD, coronary artery disease; CSI, calcification score index; EF, ejection
fraction of the left ventricle; FRS, Framingham risk score; LVMI, left
ventricle mass index; MAC, mitral annulus calcification; TTE, transthoracic
echocardiography.
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disease, Int J Cardiol (2009), doi:10.1016/j.ijcard.2009.01.021cification is an active, cell-mediated process. Vascular smooth
muscle cells retain pluripotential capability and can transform
into osteoblast-like cells [3].
Calcified plaque in the coronary arteries is a marker of
atheromatous-plaque burden and is predictive of future risk
of cardiovascular events [4], which is frequently used in
intervention trials, usually assessed with cardiac Computed
Tomography or electron-beam tomography through coron-
ary-artery calcium (or Agatston) score [5]. A recent con-
sensus conference concluded that a calcification index should
be developed, to facilitate the ability of the clinician to di-
agnose vascular and valvular calcification in order to predict
which patients would have adverse cardiovascular outcomes
[6]. Echocardiography is a low cost, portable, facile andc echocardiography in patients with known or suspected coronary artery
Fig. 1. Quantification of ARS — transthoracic parasternal long axis view; score 0 — normal aortic root, score 1 — enhanced echogenicity of the aortic root.
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ARTICLE IN PRESSradiation-free technique with obvious potential to detect and
quantify vascular and valvular calcifications.
The attachment points of the aortic andmitral valves to their
respective annuli are sites of turbulent blood flow, where there
is a tendency for atherosclerosis to initiate [7,8].Mitral annulus
calcification (MAC), aortic valve sclerosis (AVS), and aortic
root sclerosis (ARS) detected by echocardiography, have been
associated with atherosclerosis [9–11].
The aim of the present work is to evaluate a single and simple
objective semi-quantitative echocardiographic cardiovascular
Calcium Score Index (CSI), a new algorithm using the simple
transthoracic echocardiography parameters (MAC, AVS, ARS),
that could be used in the clinical routine for a better charac-
terization of the risk of developing cardiovascular disease.
This echocardiography-based cardiovascular calcification
index (CSI) was compared to time-honored clinical predictors
of coronary artery disease, such as the FraminghamRisk Score
(FRS) [12], with established echocardiographic markers of
risk, such as left ventricle mass index (LVMI) [13,14], and
coronary angiographic descriptions of anatomic coronary
artery disease, such as the angiographic Duke score [15].Fig. 2. Quantification of AVS— transthoracic parasternal short axis view at the lev
echogenicity of all aortic cuspids; score 6 — calcification of all aortic cuspids.
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2.1. Study population
We enrolled a total number of 214 consecutive patients,
with suspected or known coronary artery disease, hospita-
lized in our Institute between February 2006 and March
2007. All these patients underwent: 1) complete transthor-
acic echocardiography in the first 24 h before reperfusion
treatment in all the patients with a clinically stable condition,
and in the previous 2 h in patients who needed urgent
revascularization, 2) the Framingham risk score evaluation,
and 3) coronary angiography. Patients with valvular stenosis
(rheumatic or degenerative), prosthetic valves, or poor trans-
thoracic acoustic window were excluded. 15 patients (7%)
were excluded from the study due to a poor transthoracic
acoustic window which did not allow an optimal visualiza-
tion of the aortic root, the aortic valve and the mitral annulus.
The presence of valvular stenosis (rheumatic or degenera-
tive) and of a prosthetic valve was found in 32 patients (15%)
who were excluded from the study population.el of the great vessels; score 0— normal aortic valve; score 3— enhanced
c echocardiography in patients with known or suspected coronary artery
Fig. 4. The quantification of CSI (calcification score index) — RC = right
coronary cuspid, LC = left coronary cuspid, NC = non-coronary cuspid,
ARS = aortic root sclerosis, AVS = aortic valve sclerosis, MAC = mitral
annulus calcification.
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ARTICLE IN PRESS2.2. Transthoracic echocardiography (TTE)
Two-dimensional complete echocardiographic studieswere
performed in all patients by use of a commercially available
system (Biosound Esaote MyLab; Hewlett-Packard SONOS
7500; Philips iE33), and emphasising the study of the aortic
valve, aortic root and mitral annulus using the classical views:
the parasternal long axis for the assessment of the aortic root
(Fig. 1), the parasternal short axis at the level of the great
vessels for the aortic valve (Fig. 2), and the apical four-
chamber view and parasternal long axis for the mitral annulus,
respectively (Fig. 3) [16]. In all cases, pre and post processing
settings in each patient were tailored to optimize the display of
cardiac structures at the beginning of each examination and
thereafter were left unchanged throughout the study [17].
The aortic root sclerosis (ARS) was defined by an increased
echogenicity and/or by thickening of the walls (≥2.2 mm),
following the criteria proposed by Tolstrup et al. [18]. An
enhanced echogenicity and thickening of the cuspids or the
presence of the calcifications characterized the aortic valve
sclerosis (AVS) [11]. The TTE criteria for mitral annulus cal-
cification (MAC) included an intense echo-producing struc-
ture located at the junction of the atrioventricular groove and
posterior mitral leaflet. MAC was quantified from mild to
severe, considering its thickness and length [19].
We designed an algorithm to quantify the progression of
atherosclerosis at the level of aortic root, aortic valve, and
mitral annulus, which is illustrated in Fig. 4. The sum of the
points obtained was called the calcification score index (CSI),Fig. 3. Quantification of MAC transthoracic parasternal long axis view (top)— trans
score 1— mild calcification of the mitral annulus, score 2— moderate calcification
Please cite this article as: Corciu AI, et al, Cardiac calcification by transthoraci
disease, Int J Cardiol (2009), doi:10.1016/j.ijcard.2009.01.021with a range from 0 (normal) to 10 (diffuse calcification of the
aortic root, aortic valve and mitral annulus).
All other echocardiographic variables were measured
following recommendations of American Society of Echocar-
diography [16], in particular ejection fraction (EF) and LVMI.
2.3. Framingham risk score (FRS)
FRS is a simple coronary disease prediction algorithm en-
compassing the well-known risk factors [20]. To calculate itthoracic apical four-chamber view (bottom); score 0— normal mitral annulus,
of the mitral annulus, score 3— severe calcification of the mitral annulus.
c echocardiography in patients with known or suspected coronary artery
Table 1
The inter- and intra-observer variability on CSI
Inter Intra
Bias 0.13 0.40
Limit of agreement (+) 1.41 1.87
Limit of agreement (−) −1.15 −1.07
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ARTICLE IN PRESSwe used the following variables: age, gender, systolic blood
pressure, diastolic blood pressure, history of smoking, dia-
betes mellitus, HDL cholesterol and total cholesterol, con-
sidering a FRS≤10 to characterize the patients at low risk to
develop a cardiovascular disease, a FRS≥11 and ≤20 at
average risk, and a FRS≥21 at high risk.
2.4. Coronary angiography
All the patients underwent the coronary angiography,
using Duke score for the estimation of the extent of the
coronary artery disease (CAD), with a range from 0 (no
CAD≥50%) to 100 (left main disease≥95%) [15]. This
index takes into account not only the number of major
diseased vessels, but also any significant involvement of the
left anterior descending coronary artery, particularly when
there is involvement of the proximal segment and/or prox-
imal segment stenosis is severe (i.e., ≥95%).
2.5. Statistical analysis
Parametric data are expressed as mean±SD and non-
parametric data were given as frequency and percentage.
Groups were compared for categorical data or frequency of
events using the χ2 test and for continuous variables using
unpaired Student's t-test, Anova F-test and Kruskal–Wallis
test. All tests were 2-sided, and pb0.05 was considered
statistically significant. Roc-curve analysis was used to
determine the best cut-off for CSI and after that univariate
descriptive and logistic regression analysis was used to
determine which variable might have predicted CSI. StataFig. 5. Bland–Altman analysis of CSI, the difference plo
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disease, Int J Cardiol (2009), doi:10.1016/j.ijcard.2009.01.021v9.0 for Windows was used for data analysis. Anova F-test
was also used to determine if different index values of CSI
might have predicted LVMI, FRS and Duke score. Logistic
regression models were computed to examine the level of
association between CSI score on CAD status, checking for all
other risk factors. Independent variables significantly related
to the dependent variable on a bivariate level were entered into
the model. An additional stepwise selection logistic regression
was used to identify these seven variables that significantly
related to the CAD (hypercholesterolemia, familiarity, hyper-
tension, smoke history, diabetes, age, gender and CSI index).
The inter- and intraobserver reproducibility of CSI was
evaluated using Bland–Altman analysis by calculating the
bias (mean difference) and the 95% limits of agreement
(2 SD around mean difference) [21].
3. Results
3.1. The inter- and intraobserver variability
The inter- and intraobserver variability on CSI has been
evaluated separately on a set of 15 consecutive patients
(Table 1). The Bland–Altman analysis resulted in a nonsig-
nificant bias in interobserver (0.13) and intraobserver (0.40)
measurements and the 95% limits of agreement are respec-
tively 1.28 (inter) and 1.47 (intra) (Fig. 5).
The coefficient of variation for intra- and interobserver
reproducibility was b6% for the left ventricle diameter,
b10% for the left ventricle wall thickness and b25% for the
LVMI, data comparable with those already published by our
laboratory [22].
3.2. Population characteristics
The receiver operator characteristic analysis of CSI=4
served as the best cut-off for CAD identification (Fig. 6). We
divided the study population in 2 groups: Group I encompass-
ing the patients with a CSI≤4, and the Group II of those with a
CSIN4.tted against the average of the two measurements.
c echocardiography in patients with known or suspected coronary artery
Fig. 6. Receiver operating curves (ROC) of CSI in predicting CAD.
Table 3
Clinical characteristics and revascularization treatment of the population
Total Group I
(CSI≤4)
Group II
(CSIN4)
n=167 n=90 n=77
Unstable angina 29 (17.3%) 16 (17.8%) 13 (16.9%) n.s.
Exertional angina 75 (45%) 39 (43.4%) 36 (46.8%) n.s.
AMI 19 (11.4%) 10 (11.2%) 9 (11.7%) n.s.
Heart failure 27 (16.2%) 15 (16.7%) 12 (15.5%) n.s
Previous AMI 56 (33.5%) 28 (31.2%) 28 (36.45) n.s.
PTCA 56 (33.5%) 28 (31.2%) 28 (36.45) n.s.
Previous PTCA 37 (22.1%) 16 (17.8%) 21 (27.3%) n.s.
CABG 16 (9.6%) 6 (6.8%) 10 (13%) pb0.05
Previous CABG 22 (13.2%) 11 (12.2%) 11 (14.3%) n.s.
AMI = acute myocardial infarction, PTCA = percutaneous transluminal
coronary angioplasty, CABG = coronary artery bypass graft surgery; n.s. =
no significant differences.
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hospital patients (mean age 66.6±9.7 yrs, 119 men) with the
main characteristics that are presented in Table 2. There was a
statistically significant inter-group differences in age (OR=
2.04: pb0.001), systolic blood pressure (OR=1.02; pb0.03),
presence of diabetes mellitus (OR=3.95; pb0.001), presence
of nitrate treatment (OR=2.18 pb0.02) and insulin treat-
ment (OR=3.97; pb0.02). The data regarding the revascu-
larization treatment and clinical characteristics are shown in
Table 3.Table 2
Main characteristics of the population
Total Group I
n=167 n=90
Age (yrs) 66.6±9.7 64.2±1
Men 119 (71.3%) 62 (78.9
Systolic BP 135.4±21.5 131.9±
Diastolic BP 72.1±9.8 73.3±11
BSA (m2) 1.86±0.18 1.86±0
HDL cholesterol (mg/dl) 40.8±17.9 42.8±1
Total cholesterol (mg/dl) 177±42.8 181.6±
Smoke history 86 (51.5%) 42 (46.7
Hypertension 106 (63.4%) 52 (57.8
Diabetes mellitus 46 (27.5%) 14 (15.6
Ca channels antagonists 45 (26.9%) 23 (25.6
Beta-blocker treatment 100 (59.8%) 49 (54.4
ACE inhibitor treatment 86 (51.5%) 41 (45.6
Lipid lowering drug treatment 108 (64.6%) 57 (63.3
Aspirin treatment 102 (61%) 52 (57.8
Nitrate treatment 56 (33.5%) 23 (25.6
Ticlopidine treatment 31 (18.5%) 17 (18.9
Insulin treatment 16 (9.5%) 4 (4.4%
Oral hypoglycemic agents 29 (17.3%) 11 (12.2
BP = blood pressure, BSA = body surface area, ACE = angiotensin-converting en
Please cite this article as: Corciu AI, et al, Cardiac calcification by transthoraci
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The principal echocardiographic parameters assessed,
including CSI, the FRS, and the Duke score are presented
in Table 4., where it is showed that CSI, FRS, Duke
Score and LVMI were significantly different between
groups.
When the population was divided in 3 groups using FRS
to identify the patients at different risk to develop a
cardiovascular disease, the presence of aortic root sclerosis
(ARS) and of mitral annulus calcification (MAC) was higher
in patients with a FRS≥21 (pb0.0001 for ARS, pb0.027(CSI≤4) Group II (CSIN4)
n=77
0.5 69.5±8.0 pb0.001
%) 57 (74.0%) n.s.
21.4 139.6±21.1 pb0.03 (0.021)
.6 73.4±12.0 n.s.
.19 1.87±0.18 n.s.
8.4 38.5±17.3 n.s.
42.9 171.6±42.5 n.s.
%) 44 (57.1%) n.s.
%) 54 (70.1%) n.s.
%) 32 (42.1%) pb0.001
%) 22 (28.6%) n.s.
%) 51 (66.2%) n.s.
%) 45 (58.4%) n.s.
%) 51 (66.2%) n.s.
%) 50 (64.9%) n.s.
%) 33 (42.9%) pb0.02
%) 14 (18.2%) n.s.
) 12 (15.6%) pb0.02
%) 18 (23.4%) n.s.
zyme; n.s. = no significant differences.
c echocardiography in patients with known or suspected coronary artery
Table 4
The principal echocardiographic parameters, FRS, and Duke score
Total n=167 Group I (CSI≤4) n=90 Group II (CSIN4) n=77
LVEF (%) 51.1±10.9 52.4±10.6 49.7±11.2 n.s.
LVEFb50% 44 (26.3%) 19 (21.1%) 25 (32.5%) n.s.
LVEDD (cm) 5±0.75 5±0.77 5±0.71 n.s.
LVEDD/BSA (cm/m2) 2.7±0.05 2.6±0.56 2.7±0.45 n.s.
LVESD (cm) 3.6±0.96 3.5±0.97 3.6±0.95 n.s.
LVESD/BSA (cm/m2) 1.9±0.56 1.9±0.56 1.9±0.44 n.s.
LA diameter (cm) 4±0.63 3.9±0.66 4.05±0.57 n.s.
LA diameter/BSA (cm/m2) 2.1±0.33 2.1±0.31 2.1±0.35 n.s.
LA volume (ml) 48±20 45±21.1 51±18 n.s.
LA volume/BSA (ml/m2) 25±10.2 24±10.5 27.3±10 n.s.
LVM (g) 194.34±58.5 185.4±61.4 204.6±53.6 pb0.04
LVMI (g/m2) 104.7±26.6 99.1±25.1 111.1±29.2 pb0.006
Abnormal LVMI 58 (34.7%) 24 (27%) 34 (44.2%) pb0.03
MR presence 133 (79.6%) 70 (77.8%) 63 (81.8%) n.s.
CSI 3.94±2.1 2.32±1.4 5.84±1.0 pb0.0001
FRS 20.8±14.3 16.8±12.6 25.5±14.9 pb0.0001
Duke Score 29.7±23.7 24.1±23.6 35.9±22.5 pb0.002
LVEF = left ventricle ejection fraction, LVEDD = left ventricle end-diastolic diameter, LVESD = left ventricle end-systolic diameter, BSA = body surface area,
LA = left atrium, LVM = left ventricle mass, LVMI = left ventricle mass index, MR = mitral regurgitation, CSI = calcification score index, FRS = Framingham
risk score; n.s. = no significant differences.
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ARTICLE IN PRESSfor MAC) comparing to those at low risk. Considering at
least one calcification of at least one cuspid of the aortic
valve, the presence of calcification was more represented in
patients at a high risk ( pb0.0001). The mean CSI showed a
progressive statistically significant increase from a mean of
2.76±2.1 in patients at low risk to a mean of 4.11±2.3 in
patients at average risk and 4.71±1.7 at high risk ( pb0.001
low risk vs. high risk, p=0.02 low risk vs. average risk)
(Fig. 7).
Similar results are observed dividing the population in 2
groups using Duke Score to identify the patients with the
presence of coronary artery disease (CAD): the presence of
ARS, MAC and calcification of at least one aortic cuspid
were significantly different in patients with CAD (pb0.001Fig. 7. CSI in different risk groups— CSI showed a progressive statistically
significant increase from average risk group to moderate and high risk groups.
⁎ p=0.02 low risk vs. average risk; ⁎⁎ pb0.001 low risk vs. high risk.
Please cite this article as: Corciu AI, et al, Cardiac calcification by transthoraci
disease, Int J Cardiol (2009), doi:10.1016/j.ijcard.2009.01.021for ARS, pb0.022 for MAC, and pb0.013 for cuspid
calcification).
ThemeanCSI showed a progressive statistically significant
increase from a mean of 3.2±2.1 in patients without the
presence of coronary artery disease to a mean of 4.3±2.1 in
patients with the presence of coronary artery disease (p=
0.003) (Fig. 8). Therewas a significant difference betweenCSI
in patients with single vessel CAD compared with those
double and triple vessel CAD (pb0.002).
We performed multivariate logistic regression using those
variables that were found to differentiate between CAD andFig. 8. CSI association with the presence of CAD — the mean CSI was
significantly higher in patients with CAD. ⁎ p=0.003.
c echocardiography in patients with known or suspected coronary artery
Table 5
Predictors of CAD
Univariate Multivariate
OR 95%CI p OR 95%CI p
Hypercholesterolemia 3.2 1.499–6.831 b0.05 3.74 1.667–
8.529
b0.002
Familiarity 0.81 0.416–1.587
Hypertension 1.46 0.747–2.878
Smoke history 1.09 0.567–2.101
Diabetes 3.343 1.379–8.103 b0.05 2.84 1.101–
7.717
b0.036
Age 1.01 0.979–1.047
Gender 0.3 0.152–0.624 b0.05
CSI 1.26 1.080–1.486 b0.05 1.2 1.010–
1.431
b0.038
LVMI 1.1 0.552–2.223
LA diameter 0.881 0.456–1.705
Fig. 9. CSI association with LVMI — in patients with abnormal LVMI the
mean CSI was significantly higher comparing to the mean CSI in patients
with normal LVMI. ⁎ p=0.002.
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ARTICLE IN PRESSno-CAD at a significant level of 0.05. Of the eight variables
(hypercholesterolemia, familiarity, hypertension, smoke
history, diabetes, age, gender and CSI), only hyper-
cholesterolemia, diabetes, gender and CSI were individually
significant predictors of CAD status (pb0.05). There was a
statistically significant inter-group difference in the presence
of hypercholesterolemia (OR=3.74; pb0.002), presence of
diabetes mellitus (OR=2.84; pb0.036), and in the CSI score
(OR=1.20; pb0.038) (Table 5). The CSI score odds ratio
(OR), reflects the positive response relative to increase of
one unit in the CSI after checking for all other effects in the
model.
The fit of this model suggest that the model with CSI,
hypercholesterolemia and diabetes is preferable to the
restricted model with hypercholesterolemia and diabetes,
also comparing the two models with the LR test for nested
models (LR chi2(1)=4.42; p=0.036). We built also the
model including the global risk assessed by FRS which
showed the additive value of CSI to the FRS for the
prediction of coronary artery disease (LR chi2(1)=5.85;
p=0.015).
Analyzing differences in patients with increasing left ven-
tricle mass index (LVMI), the mean CSI showed a progres-
sive statistically significant increase from a mean of 3.6±2.2
in patients with normal LVMI to a mean of 4.7±2.0 in pa-
tients with abnormal LVMI (p=0.002) (Fig. 9).
An abnormal CSI (N4) result in a 72% chance of pre-
dicting a medium-to- high FRS, a 77% chance of predicting
the presence of CAD, and a 61% chance of predicting an
abnormal LVMI.
4. Discussion
Previous reports have noted an association between ARS,
AVS, MAC and atheroscleorsis [9–11,23]. To our knowl-
edge, this study is the first to develop a unique index,
encompassing all three echocardiographic parameters, called
calcification score index. The major findings of this study isPlease cite this article as: Corciu AI, et al, Cardiac calcification by transthoraci
disease, Int J Cardiol (2009), doi:10.1016/j.ijcard.2009.01.021that the calcification score index, expressed by the sum
between ARS, AVS and MAC, assessed by transthoracic
echocardiography, is associated with Framingham risk score,
Duke score and LVMI.
4.1. Comparison with previous studies
Several pathologic and echocardiographic studies have
demonstrated a strong association between AVS [24,25],
ARS [24], MAC [18,26] and risk factors such as age, male
gender, hypertension, cholesterol, diabetes, and smoking.
Previous studies have also shown that patients with AVS and
MAC undergoing coronary angiography have a higher prev-
alence of CAD [24,25,27]. Our study showed the association
between ARS, AVS, MAC and the presence of coronary
artery disease and the cardiovascular risk, confirming data
presented by the previous studies, but also the fact that sum-
ming all three parameters (ARS, AVS and MAC) in so-called
“calcification score index-CSI” preserves the significantly
association.
Systemic endothelial dysfunction and increased common
artery intima-media thickness (IMT) are implicated as early
events of atherosclerosis. Sgorbini et al. [23] reported that
the mean of IMT increases linearly with increasing valvular
calcification score (MAC and AVS), and Poggianti et al. [28]
showed that AVS is associated with systemic endothelial
dysfunction.
Aortic sclerosis is common in the elderly and is associated
with an increase of approximately 50% in the risk of death
from cardiovascular causes and the risk of myocardial in-
farction, even in the absence of hemodynamically significant
obstruction of the left ventricle outflow [11]. It is also known
that total and cardiovascular mortality risk increases with the
increasing left ventricle mass index (LVMI), independent of
other cardiovascular risk factors [14]. CSI was significantly
correlated with LVMI, suggesting that our index could have
a prognostic value.c echocardiography in patients with known or suspected coronary artery
8 A.I. Corciu et al. / International Journal of Cardiology xx (2009) xxx–xxx
ARTICLE IN PRESS4.2. Study limitations
The sample for this study may not be representative of the
general population. The selected patients were scheduled to
undergo coronary angiography for a clinical indication; this
inclusion criterion might have skewed the spectrum of the
population toward advanced forms of CAD. We did not use a
digitized method to identify AVS, ARS and MAC. This
could have caused a verification bias and may affect the
reproducibility in identifying cardiac calcifications. Never-
theless, the semi-quantitative “eyeball” method is the one
currently adopted in everyday clinical echocardiographic
practice, and our intention was to find a very simple instru-
ment that could be at hand to everybody, without the ne-
cessity of further supplementary analysis.
The inter- and intraobserver agreement of CSI was very
good, and therefore acceptable for a simple method which
does not increase the analysis time of a standard transthor-
acic echocardiography.
Major advances in imaging techniques using multislice
detector CT and EBCT have facilitated the diagnosis of
arterial calcification in vivo [29]. In patients on hemodia-
lysis, the measurement of cardiovascular calcification can be
greatly simplified with the use of echocardiography [30]. In
our study we propose an alternative to EBCT for calcifica-
tion assessment. When comparing the different imaging
modalities, however, one must keep in mind that echocar-
diography is radiation free and is more cost-effective than
other techniques [29].
The missing data concerning a possible value of CSI in
predicting the risk for a subsequent cardiovascular event is
one of the biggest limitation of our study, which needs to be
studied in more depth. Additionally, whether our findings are
sufficient to indicate a widespread use of echocardiography
in those patients for risk stratification requires further stud-
ies. At present, we can consider CSI as a “promising” or
“developing” biomarker, with known accuracy and reprodu-
cibility under highly controlled conditions.
5. Conclusions
Calcification score index calculated as the sum of aortic root
sclerosis, aortic valve sclerosis, andmitral annulus calcification,
is associated with risk factor profile, coronary atherosclerosis
and left ventricle mass index. This observation may provide a
new tool useful for the cardiovascular risk stratification with
standard transthoracic echocardiography. The low cost, por-
table, facile and radiation free nature of the ultrasound approach
make CSI an attractive candidate in the ongoing search for the
ideal marker of vascular and valvular calcification.
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